Tenecteplase versus Alteplase Time-to-Treatment Metrics in Large Vessel Occlusion Stroke: A Comparative Analysis from a U.S. Healthcare System (P5-13.015)
To compare large vessel occlusion stroke (LVOS) time-to-treatment metrics between patients receiving thrombolysis with alteplase (TPA) and tenecteplase (TNK) prior to endovascular treatment (EVT).
Authors
- Lisa Wasko
- Anthony Noto (ORCID: https://orcid.org/0000-0002-1624-7193)
- Samantha Doucoure
- Clemens Maria Schirmer (ORCID: https://orcid.org/0000-0003-1743-8781)
- Philipp Hendrix (ORCID: https://orcid.org/0000-0003-0017-5049)
- Prateeka Koul (ORCID: https://orcid.org/0000-0001-9313-0354)
- T Bielinski (ORCID: https://orcid.org/0000-0003-1270-1923)
- Kelsey E. Kline
- Veronica Bohl
- Gary J. Badger
Institutions
- Geisinger Medical Center (US)
- Geisinger Wyoming Valley Medical Center (US)
- Geisinger Commonwealth School of Medicine (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000208928
- Primary Topic
- Acute Ischemic Stroke Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00